bf/NASDAQ:KPTI_icon.jpeg

COM:KARYOPHARM

Karyopharm Therapeutics Inc.

  • Stock

Last Close

0.78

21/11 21:00

Market Cap

107.99M

Beta: -

Volume Today

278.50K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
387K
-
229K
40.83%
250K
9.17%
154K
38.40%
1.60M
942.21%
30.34M
1,790.09%
40.89M
34.80%
108.08M
164.31%
209.82M
94.12%
157.07M
25.14%
146.03M
7.03%
cost of revenue
2.41M
-
2.71M
12.38%
3.40M
25.77%
5.21M
53.23%
5.47M
4.97%
gross profit
387K
-
229K
40.83%
250K
9.17%
154K
38.40%
1.60M
942.21%
30.34M
1,790.09%
38.49M
26.87%
105.38M
173.81%
206.42M
95.88%
151.86M
26.43%
140.56M
7.44%
selling and marketing expenses
general and administrative expenses
5.88M
-
15.95M
170.99%
21.58M
35.33%
23.95M
10.96%
24.87M
3.85%
48.85M
96.41%
143.85M
-
145.40M
1.08%
131.88M
9.30%
selling general and administrative expenses
5.88M
-
15.95M
170.99%
21.58M
35.33%
23.95M
10.96%
24.87M
3.85%
48.85M
96.41%
105.42M
115.82%
126.42M
19.92%
143.85M
13.79%
145.40M
1.08%
131.88M
9.30%
research and development expenses
28.45M
-
60.13M
111.33%
97.74M
62.56%
86.94M
11.06%
107.27M
23.39%
161.37M
50.43%
122.34M
24.19%
150.81M
23.27%
160.84M
6.65%
148.66M
7.57%
138.22M
7.02%
other expenses
-27K
-
-2K
92.59%
10K
600%
-81K
910%
-33K
59.26%
-50K
51.52%
206K
512%
-85K
141.26%
-83K
2.35%
-356K
328.92%
cost and expenses
34.34M
-
76.08M
121.55%
119.33M
56.85%
110.89M
7.07%
132.14M
19.17%
210.22M
59.08%
230.17M
9.49%
279.94M
21.62%
308.09M
10.06%
299.28M
2.86%
275.57M
7.92%
operating expenses
34.34M
-
76.08M
121.55%
119.33M
56.85%
110.89M
7.07%
132.14M
19.17%
210.22M
59.08%
227.76M
8.34%
277.23M
21.72%
304.69M
9.90%
294.06M
3.49%
270.10M
8.15%
interest expense
-3K
-
1K
133.33%
-895K
89,600%
-1.29M
44.58%
-1.62M
24.96%
2.49M
254.17%
15.65M
527.64%
27.14M
73.45%
26.05M
4.03%
25.00M
4.03%
23.82M
4.69%
ebitda
-33.95M
-
-75.78M
123.20%
-119.08M
57.14%
-110.73M
7.01%
-130.54M
17.89%
-175.89M
34.74%
-183.90M
4.56%
-168.82M
8.20%
-97.77M
42.09%
-139.93M
43.11%
-129.01M
7.80%
operating income
-33.95M
-
-75.85M
123.41%
-119.08M
57.00%
-110.73M
7.01%
-130.54M
17.89%
-179.88M
37.80%
-189.28M
5.22%
-171.85M
9.21%
-98.27M
42.82%
-142.20M
44.70%
-129.54M
8.90%
depreciation and amortization
144K
-
323K
124.31%
634K
96.28%
717K
13.09%
713K
0.56%
4.00M
460.31%
5.37M
34.47%
3.03M
43.67%
497K
83.58%
2.28M
357.95%
530K
76.71%
total other income expenses net
3K
-
-27K
1,000%
-2K
92.59%
10K
600%
-81K
910%
1.50M
1,954.32%
-10.28M
784.09%
-24.11M
134.69%
-25.55M
5.95%
-22.72M
11.07%
-13.24M
41.74%
income before tax
-33.95M
-
-75.78M
123.22%
-118.18M
55.96%
-109.44M
7.40%
-128.92M
17.80%
-178.38M
38.36%
-199.55M
11.87%
-195.96M
1.80%
-123.82M
36.81%
-164.92M
33.19%
-142.78M
13.43%
income tax expense
-3K
-
-69K
2,200%
-895K
1,197.10%
139K
115.53%
63K
54.68%
26K
58.73%
40K
53.85%
309K
672.50%
268K
13.27%
369K
37.69%
323K
12.47%
net income
-33.95M
-
-75.78M
123.22%
-118.18M
55.96%
-109.58M
7.28%
-128.98M
17.71%
-178.41M
38.32%
-199.59M
11.87%
-196.27M
1.66%
-124.09M
36.78%
-165.29M
33.20%
-143.10M
13.43%
weighted average shs out
6.07M
-
31.14M
413.14%
35.62M
14.40%
37.52M
5.34%
45.90M
22.32%
56.78M
23.70%
61.95M
9.11%
72.04M
16.28%
75.22M
4.41%
81.87M
8.84%
114.22M
39.51%
weighted average shs out dil
6.07M
-
31.14M
413.14%
35.62M
14.40%
37.52M
5.34%
45.90M
22.32%
56.78M
23.70%
61.95M
9.11%
72.04M
16.28%
75.22M
4.41%
81.87M
8.84%
114.22M
39.51%
eps
-5.59
-
-2.43
56.53%
-3.32
36.63%
-2.92
12.05%
-2.81
3.77%
-3.14
11.74%
-3.22
2.55%
-2.72
15.53%
-1.65
39.34%
-2.02
22.42%
-1.25
38.12%
epsdiluted
-5.59
-
-2.43
56.53%
-3.32
36.63%
-2.92
12.05%
-2.81
3.77%
-3.14
11.74%
-3.22
2.55%
-2.72
15.53%
-1.65
39.34%
-2.02
22.42%
-1.25
38.12%

All numbers in (except ratios and percentages)